期刊文献+

76例医院获得性肺炎患者病原学分布及耐药性分析 被引量:1

Distribution and drug resistance of pathogens in 76 patients with hospital acquired pneumonia
下载PDF
导出
摘要 目的:探讨医院获得性肺炎(HAP)患者的病原学分布及耐药性。方法:采集76例HAP患者的呼吸道分泌物标本进行检测。结果:76例HAP患者病原学检测阳性,其中7例为混合感染,分离鉴定出病原菌85株,以革兰氏阴性菌为主,其次为革兰氏阳性菌;革兰氏阴性菌中主要致病菌为铜绿假单胞菌、肺炎克雷伯菌、鲍氏不动杆菌,对氨苄西林钠、庆大霉素等的耐药率均在50.00%以上。革兰氏阳性菌中主要为金黄色葡萄球菌、凝固酶阴性葡萄球菌,对常用抗菌药物耐药性均较高,两者均未发现万古霉素耐药株。结论:HAP致病病原菌以革兰氏阴性菌为主,细菌耐药严重,而且出现耐多药菌株,应根据药敏结果慎重合理选用抗生素,同时采取措施控制耐药菌传播,降低医院感染率。 Objective: To investigate distribution and drug resistance of pathogens in 76 patients with hospital acquired pneumonia( HAP). Methods: The respiratory tract secretion specimens from 76 patients with HAP were collected and detected by the CDC. Results: The 76 cases of HAP were positive in the pathogenic detection,7 of them were mixed infection,and 85 strains could be isolated and identified. The gram negative bacteria were the main pathogenic bacteria,followed by gram positive bacteria. The main pathogenic bacteria in the gram negative bacteria were Pseudomonas aeruginosa bacteria,pneumonia Klebsiella,Acinetobacter baumannii,whose ampicillin and gentamicin resistance rate were above 50. 00%. The main pathogenic bacteria in the gram positive bacteria were Staphylococcus aureus and coagulase negative staphylococci,whose antimicrobial drug resistance was higher. No vancomycin resistant strains were found in the two groups. Conclusions: HAP pathogenic bacteria is mainly the gram negative bacteria with serious bacterial resistance and multidrug resistant strains,therefore,it should rational use antibiotics according to the drug sensitivity results,and should take measures to control the spread of resistant bacteria and reduce the hospital infection rate.
作者 孙海
出处 《中国民康医学》 2016年第1期1-2,7,共3页 Medical Journal of Chinese People’s Health
关键词 医院获得性肺炎 病原学 耐药性 Hospital acquired pneumonia Pathogen Drug resistance
  • 相关文献

参考文献6

二级参考文献30

  • 1胡必杰,魏丽,张秀珍,唐英春,倪语星,黎毅敏,郭纪全,胡云建,张扣兴,杨莉.医院获得性肺炎发病时间对病原构成影响的回顾性队列研究[J].中华结核和呼吸杂志,2005,28(2):112-116. 被引量:48
  • 2代永静,王建荣.重症监护病房医院感染危险因素及护理预防措施[J].中华医院感染学杂志,2007,17(2):239-240. 被引量:100
  • 3陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 4河东捷,管向东.重症医学[M].北京:人民卫生出版社,2009:369.
  • 5Masterton R G,Galloway A,French G,et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pn- eumonia of the British Society for Antimicrobial Chemo- therapy [ J ].J Antimicrob Chemother, 2008,62 ( 1 ) : 5-34.
  • 6Lynch J P 3rd.Hospital-acquired pneumonia risk factors, microbiology,and Treatment [Jl.Chest,2001,119 (2 S1) : 373S-384S.
  • 7NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003 [ J ]. Am J Infect Control, 2003,31 (8) : 481.
  • 8Lima AL, Oliveira PR, Paula AP. Acinetobacter infection[J].N Engl J Med, 2008, 358(26) :2846.
  • 9Leung E, Weil DE, Raviglione M, et al. The WHO policy package to combat antimicrobial resistance [J]. Bull World Health Organ, 2011,89 (5) : 390.
  • 10何礼贤,陈雪华,潘珏,胡洁,瞿介明,胡必杰,朱惠如.重症监护室医院获得性肺炎发病及预后危险因素分析[J].中华结核和呼吸杂志,1998,21(9):532-534. 被引量:26

共引文献294

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部